Assuntos
Antipsicóticos/farmacologia , Antipsicóticos/farmacocinética , Lobo Frontal/efeitos dos fármacos , Lobo Frontal/metabolismo , Mudanças Depois da Morte , Transtornos Psicóticos/tratamento farmacológico , Esquizofrenia Paranoide/tratamento farmacológico , Esquizofrenia/metabolismo , Superóxido Dismutase/metabolismo , Lobo Temporal/efeitos dos fármacos , Lobo Temporal/metabolismo , Adulto , Técnicas de Cultura , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Quantitative autoradiographic analysis of beta-adrenergic binding sites was conducted in human postmortem hypothalamus using the radioligand 125I-pindolol. The focus was on the hypothalamic nuclei most clearly involved in corticotropin-releasing hormone (CRH) release, the PVN and SON. For comparison, the distribution of hypothalamic beta-adrenergic receptors was evaluated in the rat. A high level of beta-adrenergic receptor binding was found in the human paraventricular nucleus (PVN) and supraoptic nucleus (SON), but not in the rat. The majority of the beta-adrenergic receptors found in the human hypothalamus were of the beta 2-subtype. In contrast, in the rat hypothalamus, the majority of receptors were of the beta 1-subtype. These results show that the anatomical loci exist for direct beta-adrenergic influence on hypothalamic neuroendocrine function in the human and that the topography of beta-adrenergic receptors is markedly different in the rat and human hypothalamus.